Utility of creatinine/cystatin C ratio as a predictive marker for adverse effects of chemotherapy in lung cancer: A retrospective study

Conclusion
The Cr/CysC ratio could serve as a useful predictive marker for chemotherapy-related adverse effects in patients with NSCLC.

Source: Journal of International Medical Research - July 10, 2015 Category: Research Authors: Suzuki, K., Furuse, H., Tsuda, T., Masaki, Y., Okazawa, S., Kambara, K., Inomata, M., Miwa, T., Matsui, S., Kashii, T., Taniguchi, H., Hayashi, R., Tobe, K. Tags: Clinical Notes Source Type: research